BRIEF — Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026

Oct 14 (Reuters) — Oncolytics Biotech Inc: Oncolytics Biotech® Provides Update On Goblet Study Clinical Data And Final Pancan Grant Payment Oncolytics Biotech - Final Cohort 4 Results Expected In Q4 2026; Initial Cohort 5 Results In H1 2027 Oncolytics Biotech - To Receive Final Pancan Grant Payment Later This Quarter Source text:... Further company coverage: ONCY.O (Reuters.Briefs@thomsonreuters.com;)